NSPR InspireMD, Inc.: Operating Margin

Corporate emblem and logo of InspireMD Inc. (NSPR)

The yield from core operations, as reflected in GURU.Markets quotes, reveals the pragmatic approach of the Israeli management regarding expansion into the US. Unique embolism protection allows InspireMD, Inc. (NSPR) to maintain high profitability. Demand for stents remains independent of economic conditions, driven instead by an aging population. The current status is -467.70, which helps assess business efficiency without unnecessary noise.

NSPR: InspireMD Operating Margin 07/04/2022 - 11/19/2026

InspireMD, Inc. - analytical breakdowns and key metrics (NSPR)

- share price and consensus valuation forecast:
Fundamental company analysis:NSPR, InspireMD Inc
Brand item of InspireMD Inc.

Operating margin is calculated as the ratio of operating income to revenue, providing a real-time assessment of cost management efficiency and internal business profitability. This indicator measures the company's ability to generate cash flow before accounting for financial obligations, while the current operating margin confirms the pricing power of InspireMD, Inc. (NSPR) due to the exclusivity of its anti-embolic technologies.

Competitors of InspireMD, Inc. (NSPR)

BSX (Boston Scientific Corporation Inc.) - Operating Margin|Operating Margin Edwards Lifesciences Inc.|Operating Margin RMD|Operating Sales Margin Insulet Corporation PODD|Operating Profitability Zimmer Biomet ZBH|CooperVision - Operating Profitability|ALGN - Operating Profitability|GMED: Operating Profitability|TMDX (TransMedics Corp) - Operating Sales Margin|Alphatec Holdings, Inc. - Operating Profit Rate|AORT (Artivion Corp) - Operating Margin|Operating Return on Sales Enovis Corp ENOV|Operating Profitability Integra LifeSciences Corp (IART)|Establishment Labs (ESTA) - Operating Profitability Margin|iLet Bionic Pancreas - Operating Sales Margin|Operating Margin IRADIMED CORPORATION IRMD|Embecta Corp - Operating Margin|Profitability of Operations Tandem Diabetes Care Inc TNDM|Axogen (AXGN) - Operating Profitability|Operating Profit Margin SIBN (SI-BONE Medical)|Operating Profitability orthofix.com|Operating Return on Sales bioventus.com BVS|Operating Margin KIDS|TMCI - Operating Return on Sales|Operating Profitability Strata Critical Medical Inc SRTA|CARL: Return on Sales by Operating Profit|RXST: Operating Sales Margin|clearpointneuro.com - Operating Profit Ratio|Stereotaxis Inc (STXS) - Operating Profitability|Return on Sales by Operating Profit STIM|SGHT (Sight Sciences Inc) - Operating Margin|OBIO: Operating Profit Rate|Operating Margin ANIK|Jin Medical International Ltd - Return on Sales by Operating Profit|Operating Margin VANI (Vivani Medical Inc)|XTNT: Return on Sales by Operating Profit|NMTC - Operating Profitability|MODD: Operating Profitability|MYO: Operating Margin|envoymedical.com - Operating Profit Rate|Operating Sales Margin VVOS|Operating Return on Sales enVVeno NVNO|Operating Margin SINT|TNON - Operating Return on Sales|Operating Profitability ReWalk Robotics LFWD|AMIX: Return on Sales by Operating Profit|IVF - Operating Profitability|Operating Return on Sales Bone Biologics Corp|AXNX: Operating Margin|Operating Sales Margin BIOLASE, Inc.|Operating Sales Margin DYNT|Operating Sales Margin Paragon 28 (FNA)|Operating Profitability INVO Bio (INVO)